Atlas Trials

Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer

Clinical trial NCT02773004 · COMPLETED

Trial details

NCT number
NCT02773004
Sponsor
UNICANCER
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2016-09-01
Primary completion
2017-09-01
Enrollment
203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.